Search

Author/Creator Erb, David

1. Design and performance of a dedicated coherent X‐ray scanning diffraction instrument at beamline NanoMAX of MAX IV. (16th March 2022)

Authors:
Carbone, Dina; Kalbfleisch, Sebastian; Johansson, Ulf; Björling, Alexander; Kahnt, Maik; Sala, Simone; Stankevic, Tomas; Rodriguez-Fernandez, Angel; Bring, Björn; Matej, Zdenek; Bell, Paul; Erb, David; Hardion, Vincent; Weninger, Clemens; Al-Sallami, Hussein; Lidon-Simon, Julio; Carlson, Stefan; ...
Journal:
Journal of synchrotron radiation
Issue:
Volume 29:Part 3(2022)
Page Start:
876
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. NanoMAX: the hard X‐ray nanoprobe beamline at the MAX IV Laboratory. (5th October 2021)

Authors:
Johansson, Ulf; Carbone, Dina; Kalbfleisch, Sebastian; Björling, Alexander; Kahnt, Maik; Sala, Simone; Stankevic, Tomas; Liebi, Marianne; Rodriguez Fernandez, Angel; Bring, Björn; Paterson, David; Thånell, Karina; Bell, Paul; Erb, David; Weninger, Clemens; Matej, Zdenek; Roslund, Linus; Åhnberg, ...
Journal:
Journal of synchrotron radiation
Issue:
Volume 28:Part 6(2021)
Page Start:
1935
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Non-typeable Haemophilus influenzae–Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b trial. Issue 5 (May 2022)

Authors:
Andreas, Stefan; Testa, Marco; Boyer, Laurent; Brusselle, Guy; Janssens, Wim; Kerwin, Edward; Papi, Alberto; Pek, Bonavuth; Puente-Maestu, Luis; Saralaya, Dinesh; Watz, Henrik; Wilkinson, Tom M A; Casula, Daniela; Di Maro, Gennaro; Lattanzi, Maria; Moraschini, Luca; Schoonbroodt, Sonia; Tasciotti...
Journal:
Lancet
Issue:
Volume 10:Issue 5(2022)
Page Start:
435
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial. Issue 3 (March 2021)

Authors:
Harrison, Tim W; Chanez, Pascal; Menzella, Francesco; Canonica, Giorgio Walter; Louis, Renaud; Cosio, Borja G; Lugogo, Njira L; Mohan, Arjun; Burden, Annie; McDermott, Lawrence; Garcia Gil, Esther; Zangrilli, James G; Pohl, Wolfgang; Voves, Robert; Deschampheleire, Maud; Louis, Renaud; Martinot, ...
Journal:
Lancet
Issue:
Volume 9:Issue 3(2021)
Page Start:
260
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗